Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Medical University of South Carolina
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Abramson Cancer Center at Penn Medicine
Mayo Clinic
Dana-Farber Cancer Institute
Columbia University
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Stanford University
Children's Hospital Medical Center, Cincinnati
MaineHealth
Mayo Clinic
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Fudan University
National Cancer Institute (NCI)
University of Washington
National Cancer Institute (NCI)
University of Pennsylvania
Jonsson Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Regimmune Corporation
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
Sarcoma Alliance for Research through Collaboration
Maastricht Radiation Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indiana University
National Cancer Institute (NCI)
Second Affiliated Hospital, School of Medicine, Zhejiang University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
University of Washington
European Myeloma Network B.V.
Grupo Espanol de Investigacion en Sarcomas
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Jonsson Comprehensive Cancer Center
Fred Hutchinson Cancer Center